Cyclarity Therapeutics, Inc. — Form D
Cyclarity Therapeutics, Inc. of Novato, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-30. The offering totals $12.8M, of which $10.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-12-30
- Form: D
- Accession: 0001794705-24-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $12.8M
- Amount sold: $10.3M
- Remaining: $2.5M
- Investors: 19
- Date of first sale: 2024-12-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-533653
Issuer
- Name: Cyclarity Therapeutics, Inc.
- CIK: 0001794705
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 8001 Redwood Blvd, Novato, CA, 94945
- Phone: 6509065631
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Michael Kope | Director | Novato, CA |
| Matthew O'Connor | Director | Austin, TX |
| Michael Kope | Executive Officer | Novato, CA |
| Matthew O'Connor | Executive Officer | Austin, TX |
| Frank Schueler | Director | Mountain View, CA |
Other filings by this issuer (2)
More